Alnylam Pharmaceuticals, Inc. - 0306060, Assessing Patients' Experiences With Acute Hepatic Porphyria: Exit Interviews (Pro00053618)

  • Anderson, Karl (PI)

Project: Other project

Project Details

StatusActive
Effective start/end date10/6/2110/5/24